Related references
Note: Only part of the references are listed.Ganciclovir-resistant cytomegalovirus infection in solid organ transplant recipients: a single-center retrospective cohort study
P. G. Young et al.
TRANSPLANT INFECTIOUS DISEASE (2016)
Outcomes in Transplant Recipients Treated With Foscarnet for Ganciclovir-Resistant or Refractory Cytomegalovirus Infection
Robin K. Avery et al.
TRANSPLANTATION (2016)
CMV: Prevention, Diagnosis and Therapy
C. N. Kotton
AMERICAN JOURNAL OF TRANSPLANTATION (2013)
Cytomegalovirus in Solid Organ Transplantation
R. R. Razonable et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2013)
Updated International Consensus Guidelines on the Management of Cytomegalovirus in Solid-Organ Transplantation
Camille N. Kotton et al.
TRANSPLANTATION (2013)
Incidence and Outcomes of Ganciclovir-Resistant Cytomegalovirus Infections in 1244 Kidney Transplant Recipients
Hans-Arne Myhre et al.
TRANSPLANTATION (2011)
Use of foscarnet for cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation from a related donor
Maiko Asakura et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2010)
Drug-resistant cytomegalovirus in transplant recipients: a French cohort study
Sebastien Hantz et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Safety and efficacy of foscarnet for preemptive therapy against cytomegalovirus reactivation after unrelated cord blood transplantation
A. Takami et al.
TRANSPLANTATION PROCEEDINGS (2007)
Ganciclovir-resistant cytomegalovirus in organ transplant recipients
AP Limaye
CLINICAL INFECTIOUS DISEASES (2002)
Share Paper
